MED
Get informed when a big investor buys or sells
+ FollowUndervalued by 249.6% based on the discounted cash flow analysis.
| Market cap | $130.87 Million |
|---|---|
| Enterprise Value | $91.84 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.7 |
| Beta | 0.73 |
| Outstanding Shares | 11,135,000 |
| P/E Ratio | -5.05 |
|---|---|
| PEG | 2.25 |
| Price to Sales | 0.43 |
| Price to Book Ratio | 0.7 |
| Enterprise Value to Revenue | 0.29 |
| Enterprise Value to EBIT | -5.75 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.36 |
| Debt to Equity | 0.17 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1147▲ 7.96% |
|---|---|
| Total Calls | 932,700▼ 41.64% |
| Total Puts | 107,000▲ 90.73% |
Holdings and activity of institutional investors.
| Ownership % | 77.76%▼ 0.40% |
|---|---|
| Total Invested | $91.88M▲ 4.84% |
| Investors Holding | 120▼ 1.00% |
No data
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and ...